These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

533 related items for PubMed ID: 10983740

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Sleep latency is shortened during 4 weeks of treatment with zaleplon, a novel nonbenzodiazepine hypnotic. Zaleplon Clinical Study Group.
    Elie R, Rüther E, Farr I, Emilien G, Salinas E.
    J Clin Psychiatry; 1999 Aug; 60(8):536-44. PubMed ID: 10485636
    [Abstract] [Full Text] [Related]

  • 3. Zaleplon: a pyrazolopyrimidine sedative-hypnotic agent for the treatment of insomnia.
    Weitzel KW, Wickman JM, Augustin SG, Strom JG.
    Clin Ther; 2000 Nov; 22(11):1254-67. PubMed ID: 11117652
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Zolpidem: an update of its pharmacology, therapeutic efficacy and tolerability in the treatment of insomnia.
    Holm KJ, Goa KL.
    Drugs; 2000 Apr; 59(4):865-89. PubMed ID: 10804040
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Efficacy and safety of zaleplon at peak plasma levels.
    Mangano RM.
    Int J Clin Pract Suppl; 2001 Jan; (116):9-13. PubMed ID: 11219331
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Zaleplon - a review of a novel sedative hypnotic used in the treatment of insomnia.
    Heydorn WE.
    Expert Opin Investig Drugs; 2000 Apr; 9(4):841-58. PubMed ID: 11060714
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Eszopiclone, a nonbenzodiazepine sedative-hypnotic agent for the treatment of transient and chronic insomnia.
    Najib J.
    Clin Ther; 2006 Apr; 28(4):491-516. PubMed ID: 16750462
    [Abstract] [Full Text] [Related]

  • 18. Implications of hypnotic flexibility on patterns of clinical use.
    Lader MH.
    Int J Clin Pract Suppl; 2001 Jan; (116):14-9. PubMed ID: 11219327
    [Abstract] [Full Text] [Related]

  • 19. Residual effects of middle-of-the-night administration of zaleplon and zolpidem on driving ability, memory functions, and psychomotor performance.
    Verster JC, Volkerts ER, Schreuder AH, Eijken EJ, van Heuckelum JH, Veldhuijzen DS, Verbaten MN, Paty I, Darwish M, Danjou P, Patat A.
    J Clin Psychopharmacol; 2002 Dec; 22(6):576-83. PubMed ID: 12454557
    [Abstract] [Full Text] [Related]

  • 20. Clinically important drug interactions with zopiclone, zolpidem and zaleplon.
    Hesse LM, von Moltke LL, Greenblatt DJ.
    CNS Drugs; 2003 Dec; 17(7):513-32. PubMed ID: 12751920
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.